<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03869398</url>
  </required_header>
  <id_info>
    <org_study_id>2017-048</org_study_id>
    <nct_id>NCT03869398</nct_id>
  </id_info>
  <brief_title>Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia?</brief_title>
  <official_title>Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lahey Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lahey Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are performing this study to determine if supplementation with calcium and
      calcitriol (vitamin D) before surgery decreases the rate of hypocalcemia (low calcium) after
      surgery.

      Postoperative hypocalcemia (low calcium) is the most common complication after thyroidectomy.
      Symptoms range from numbness/tingling around the mouth and fingers to severe problems such as
      low blood pressure, irregular heartbeat, muscle cramps and uncontrollable muscle spasms.

      The current standard of practice at Lahey for patients undergoing total thyroidectomy is to
      start Tums 1500mg three times daily and Calcitriol 0.25mcg twice daily immediately after
      surgery. Also current practice is for each patient to have their calcium and albumin levels
      checked at 8 hours and 24 hours after surgery. If the corrected calcium level drops below 8.5
      or they exhibit symptoms of hypocalcemia the dose of the Tums and Calcitriol are increased
      per protocol. All patients must also follow up in 3-4 days to have their calcium and albumin
      levels rechecked.

      The investigators propose to change the above standard practice at Lahey by making only one
      change. The investigators wish to start Tums and Calcitriol 5 days before surgery, as opposed
      to after surgery. This will be the only change to the current standard of care at Lahey.

      The investigators hypothesize that initiating Tums and Calcitriol supplementation in the
      preoperative period will decrease the overall rate of postoperative hypocalcemia and its
      related symptoms. This will possibly decrease length of hospital stay, decrease cost, and
      prevent any serious complications associated with low calcium.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective of this study is to determine if treating patients with calcitriol and
      calcium prior to thyroidectomy decreases postoperative hypocalcemia. The primary outcome to
      be measured is clinical hypocalcemia, defined as peri-oral numbness and/or tingling, numbness
      and/or tingling in fingers, tetany, seizures, hypotension, palpitations. A secondary outcome
      measure of biochemical hypocalcemia will be measured. Biochemical hypocalcemia will be
      defined as a corrected calcium for albumin of less than 8.5 at 8 hours, 1 day, and 3 days
      postoperatively. Additional secondary outcome measures will be hospital length of stay, need
      for calcium gluconate IV supplementation, need for additional calcium monitoring.

      Postoperative hypocalcemia is the most common complication after thyroidectomy. Symptoms
      range from perioral numbness/tingling and tingling in fingers to severe complications such as
      hypotension, arrhythmias and tetany. In prior studies hypocalcemia after thyroidectomy can
      occur up to 50% of the time. A retrospective cohort study from 2017 shows that treating
      patients with vitamin D and calcium preoperatively decreases the rate of postoperative
      hypocalcemia. Preoperative treatment in that study included calcitriol 0.25mcg PO BID and
      Tums 1,500mg PO TID starting 5 days before surgery. This showed a significant decrease in
      postoperative hypocalcemia, decreased hospital stay, and overall decrease in cost for
      patients undergoing total thyroidectomy. This study was limited by its retrospective and
      observational nature. By performing a prospective randomized study on preoperative
      supplementation the investigators hope to provide a stronger level of evidence to support
      this practice.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">July 1, 2019</completion_date>
  <primary_completion_date type="Actual">July 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Subjects will be enrolled in the study during their pre-operative consultation with the surgeon once they have been cleared to undergo total thyroidectomy per the usual screening process. The attending surgeon or an IRB approved co investigator will perform the informed consent process (see designated co-investigators). This process will occur in the General Surgery clinic when potential subjects have their 30 minute scheduled preoperative appointment prior to going to the operating room. This process will be conducted in the same manner as the informed consent process for the operation. The nature of their condition will be discussed; the potential risks and benefits of the study will be explained to subjects. The options including not enrolling, enrolling now, and the option to withdraw from the study at any time for any reason will be explained to subjects as well. Once they have consented a consent form will be signed and the subject provided a copy.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Hypocalcemia</measure>
    <time_frame>3 days post operative</time_frame>
    <description>The main objective of this study is to determine if treating patients with calcitriol and calcium prior to thyroidectomy decreases postoperative hypocalcemia. The primary outcome to be measured is clinical hypocalcemia, defined as peri-oral numbness and/or tingling, numbness and/or tingling in fingers, tetany, seizures, hypotension, palpitations</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical hypocalcemia</measure>
    <time_frame>3 days post operative</time_frame>
    <description>A secondary outcome measure of biochemical hypocalcemia will be measured. Biochemical hypocalcemia will be defined as a corrected calcium for albumin of less than 8.5 at 8 hours, 1 day, and 3 days postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>3 days post operative</time_frame>
    <description>hospital length of stay</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Hypocalcemia</condition>
  <condition>Thyroid Diseases</condition>
  <arm_group>
    <arm_group_label>Control arm: No pre-op medications</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients undergoing total thyroidectomy are started on calcitriol 0.25mcg PO BID and Tums 1,500mg PO TID immediately postoperatively. No pre-operative medications are given</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention arm: Tums and Calcitriol pre-op</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients start calcitriol 0.25mcg PO BID and Tums 1,500mg PO TID 5 days before surgery. The five days is determined due to the time it takes vitamin D to have an effect on the guts reabsorption of calcium.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Tums</intervention_name>
    <description>start their calcitriol 0.25mcg PO BID and Tums 1,500mg PO TID 5 days before surgery. The five days is determined due to the time it takes vitamin D to have an effect on the guts reabsorption of calcium.</description>
    <arm_group_label>Intervention arm: Tums and Calcitriol pre-op</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcitriol</intervention_name>
    <description>start their calcitriol 0.25mcg PO BID and Tums 1,500mg PO TID 5 days before surgery. The five days is determined due to the time it takes vitamin D to have an effect on the guts reabsorption of calcium.</description>
    <arm_group_label>Intervention arm: Tums and Calcitriol pre-op</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients, age &gt;18, undergoing total thyroidectomy are eligible.

        Exclusion Criteria:

          -  partial thyroidectomy, lobectomy, or concurrent parathyroidectomy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Brams, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lahey Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Testa A, Fant V, De Rosa A, Fiore GF, Grieco V, Castaldi P, Persiani R, Rausei S, D'ugo D, De Rosa G. Calcitriol plus hydrochlorothiazide prevents transient post-thyroidectomy hypocalcemia. Horm Metab Res. 2006 Dec;38(12):821-6.</citation>
    <PMID>17163358</PMID>
  </reference>
  <reference>
    <citation>Roh JL, Park CI. Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy. Am J Surg. 2006 Nov;192(5):675-8.</citation>
    <PMID>17071205</PMID>
  </reference>
  <reference>
    <citation>Reeve T, Thompson NW. Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg. 2000 Aug;24(8):971-5. Review.</citation>
    <PMID>10865043</PMID>
  </reference>
  <reference>
    <citation>Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, Racadot A, Proye C. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg. 1998 Jul;22(7):718-24. Review.</citation>
    <PMID>9606288</PMID>
  </reference>
  <reference>
    <citation>Maxwell AK, Shonka DC Jr, Robinson DJ, Levine PA. Association of Preoperative Calcium and Calcitriol Therapy With Postoperative Hypocalcemia After Total Thyroidectomy. JAMA Otolaryngol Head Neck Surg. 2017 Jul 1;143(7):679-684. doi: 10.1001/jamaoto.2016.4796.</citation>
    <PMID>28418509</PMID>
  </reference>
  <reference>
    <citation>Iglesias P, DÃ­ez JJ. Endocrine Complications of Surgical Treatment of Thyroid Cancer: An Update. Exp Clin Endocrinol Diabetes. 2017 Sep;125(8):497-505. doi: 10.1055/s-0043-106441. Epub 2017 Apr 25. Review.</citation>
    <PMID>28444664</PMID>
  </reference>
  <reference>
    <citation>Docimo G, Ruggiero R, Casalino G, Del Genio G, Docimo L, Tolone S. Risk factors for postoperative hypocalcemia. Updates Surg. 2017 Jun;69(2):255-260. doi: 10.1007/s13304-017-0452-x. Epub 2017 Apr 25.</citation>
    <PMID>28444542</PMID>
  </reference>
  <reference>
    <citation>Falk SA, Birken EA, Baran DT. Temporary postthyroidectomy hypocalcemia. Arch Otolaryngol Head Neck Surg. 1988 Feb;114(2):168-74.</citation>
    <PMID>3337775</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 6, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>July 8, 2019</last_update_submitted>
  <last_update_submitted_qc>July 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypocalcemia</mesh_term>
    <mesh_term>Thyroid Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitriol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be managed by Co-investigators on a secure spread sheet in a password protected folder on the Lahey General Surgery shared drive. Subjects will be assigned a number and there will be no identifying information on this spreadsheet.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

